University of Iowa, 2008 - $18,000

The National Institute of Occupational Safety and Health (NIOSH) estimates that 5.5 million healthcare workers (pharmacists, nurses, technicians, and others) are exposed to toxic chemotherapy pharmaceuticals in the workplace. NIOSH confirms the health risks from these exposures include cancers, liver/kidney damage, infertility, miscarriages, birth defects, and congenital malformations. Independent research shows current products fall short in addressing all the market needs, with many users complaining current devices are: ineffective at eliminating exposure, difficult to use, error-prone, inefficient, and costly.

This E-Team, incorporated as J & J Solutions, is an emerging medical device company that has developed innovative technology to optimize safety, increase efficiency, and reduce the cost of preparing and administering chemotherapy pharmaceuticals. Hospital pharmacies and oncology clinics create a $500 million U.S. market potential, with a current market opportunity near $100 million and growing over 20% annually. The Company has pending patents, working product, proven technology, strong management, and commitments from cancer centers across the country.